Login / Signup

Anti-factor Xa level monitoring of low-molecular-weight heparin for prevention of venous thromboembolism in critically ill patients (AXaLPE): protocol of a randomised, open-label controlled clinical trial.

Chunmei WangYa-Chan NingLi-Po SongPei-Juan LiFeng-Hua WangMeng-Xi DingLi JiangMeiping WangQian-Qian PeiShi-Min HuHaibo Wang
Published in: BMJ open (2023)
NCT05382481.
Keyphrases
  • venous thromboembolism
  • open label
  • clinical trial
  • phase ii
  • direct oral anticoagulants
  • phase iii
  • phase ii study
  • study protocol
  • randomized controlled trial
  • double blind
  • placebo controlled